Doll Nicolas, Borger Michael A, Fabricius Alexander, Stephan Susann, Gummert Jan, Mohr Friedrich W, Hauss Johann, Kottkamp Hans, Hindricks Gerd
Clinic for Heart Surgery, Heart Center, University of Leipzig, Leipzig, Germany.
J Thorac Cardiovasc Surg. 2003 Apr;125(4):836-42. doi: 10.1067/mtc.2003.165.
Intraoperative radiofrequency ablation of atrial fibrillation (IRAAF) is a recently developed procedure being performed in an increasing number of patients. We have performed left atrial IRAAF in 387 patients since August 1998. The purpose of this article is to describe a serious complication of this procedure, namely IRAAF-induced esophageal perforation, in detail to identify possible risk factors.
Left atrial IRAAF was performed with a commercially available unipolar probe as an isolated procedure (n = 129) or in combination with mitral valve surgery (n = 163) or other surgical procedures (n = 95). Operations were performed either through a conventional sternotomy or right minithoracotomy.
Four (1%) patients had esophageal perforation after radiofrequency ablation. All 4 patients presented after an initially unremarkable postoperative course, with sudden neurologic symptoms from esophagoatrial air embolization occurring in 3 of the patients. Three patients were successfully treated with extensive esophageal resection, and one died from massive air embolism. All perforations occurred in patients undergoing minimally invasive IRAAF. Comparison with other patients undergoing isolated minimally invasive IRAAF (n = 129) failed to reveal any reliable predictors of esophageal injury, including patient body size, operating times, or radiofrequency biophysical parameters.
Left atrial IRAAF is associated with a small but definite risk of esophageal perforation. Unfortunately, we were unable to identify any risk factors for this life-threatening complication. A high degree of vigilance must be maintained for esophageal injury after IRAAF, particularly in patients with new neurologic deficits. Until safer methods of ablation are developed, we currently recommend against the use of IRAAF in patients undergoing cardiac surgery.
术中房颤射频消融术(IRAAF)是一项最近开展的手术,接受该手术的患者数量日益增多。自1998年8月以来,我们已对387例患者实施了左心房IRAAF。本文旨在详细描述该手术的一种严重并发症,即IRAAF引起的食管穿孔,以确定可能的危险因素。
使用市售单极探头实施左心房IRAAF,该手术可单独进行(n = 129),也可与二尖瓣手术(n = 163)或其他外科手术联合进行(n = 95)。手术通过传统胸骨切开术或右胸小切口进行。
4例(1%)患者在射频消融后发生食管穿孔。所有4例患者术后初期病情均无明显异常,其中3例患者因食管-心房空气栓塞突然出现神经症状。3例患者通过广泛食管切除术成功治愈,1例死于大量空气栓塞。所有穿孔均发生在接受微创IRAAF的患者中。将这些患者与其他接受单独微创IRAAF的患者(n = 129)进行比较,未发现任何可靠的食管损伤预测因素,包括患者体型、手术时间或射频生物物理参数。
左心房IRAAF与食管穿孔的小但明确的风险相关。不幸的是,我们无法识别这种危及生命并发症的任何危险因素。IRAAF术后必须高度警惕食管损伤,尤其是出现新的神经功能缺损的患者。在开发出更安全的消融方法之前,我们目前建议心脏手术患者不要使用IRAAF。